Review of patents on micro needle applicators

Recent Patents on Drug Delivery and Formulation

Volumn 5, Issue 1, 2011, Pages 11-23

  Singh, Thakur R R ^a   Dunne, Nicholas J ^a   Cunningham, Eoin ^a   Donnelly, Ryan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Active pharmaceutical ingredients; Applicator; Microconduits; Microneedle; Microneedle fabrication; Microporation; Painfreedelivery; Plunger; Transdermal drug delivery

Indexed keywords

ADHESIVE AGENT; ALENDRONIC ACID; CEFTRIAXONE; ENOXAPARIN; GLYCERYL TRINITRATE; DRUG;

ARTICLE; DISPOSABLE EQUIPMENT; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ELASTICITY; EQUIPMENT DESIGN; HUMAN; IONTOPHORESIS; MICROINJECTION; MICRONEEDLE; NEEDLE; PATENT; PRIORITY JOURNAL; SKIN PERMEABILITY; SKIN SURFACE; TRANSDERMAL PATCH; EPIDERMIS; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; PERMEABILITY; REVIEW;

ADMINISTRATION, CUTANEOUS; DRUG DELIVERY SYSTEMS; EPIDERMIS; EQUIPMENT DESIGN; HUMANS; NEEDLES; PATENTS AS TOPIC; PERMEABILITY; PHARMACEUTICAL PREPARATIONS;

EID: 79954438576     PISSN: 18722113     EISSN: 18722113     Source Type: Journal    
DOI: 10.2174/187221111794109484     Document Type: Article

References (51)

1. Williams AC. Transdermal and Topical Drug Delivery. London: Pharmaceutical Press 2003.
2. Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001; 14: 101-114.
3. Gozes S, Reshef A, Salah D. Stearyl-norleucine-vasoactiveintestinal peptide (VIP): A novel VIP analog for noninvasiveimpotence treatment. Endocrinology 1994; 134: 2121-5.
4. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008; 26(11): 1261-8.
5. Kumar R, Anil P. Modified transdermal technologies: Breaking the barriers of drug permeation via the skin. Trop J Pharm Res 2007;6(1): 633-644.
6. Noven Pharmaceuticals, Inc. Controlled Release Society: Annual Meeting 2006.
7. Wang B, Teruna S, Soltero R. Physiological, Biochemical, and Chemical Barriers to Oral Drug Delivery. In: Drug Delivery Principles and Applications. New Jersey: John Wiley & Sons Inc.2004; 15-26.
8. Anubhav A, Prausnitz MR, Samir M. Micro-scale devices fortransdermal drug delivery. Int J Pharm 2008; 364(2): 227-36.
9. Kalia YN, Naik A, James G, Richard HG. Iontophoretic drugdelivery. Adv Drug Deliv Rev 2004; 56: 619-58.
10. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation ofmammalian skin-a mechanism to enhance transdermal drugdelivery. Proc Natl Acad Sci USA 1993; 90 (22): 10504-8.
11. Birchall J, Coulman S, Anstey A, Gateley C, Sweetland H, Gershonowitz A, et al. Cutaneous gene expression of plasmid DNAin excised human skin following delivery via microchannelscreated by radio frequency ablation. Int J Pharm 2006; 312: 15-23.
12. Mitragotri S, Blankschtein D, Langer R. Ultrasound-mediatedtransdermal protein delivery. Science 1995; 269 (5225): 850-3.
13. Banga AK. Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv 2009; 6(4): 343-54.
14. Thakur, R.R.S., Garland, M.J., Cassidy, C.M., Migalska, K., Demir, Y.K., Abdelghany, S., Ryan, E., Woolfson, A.D., Donnelly, R.F. Microporation techniques for enhanced delivery of therapeuticagents. Recent Pat Drug Deliv Form 2010; 4: 1-17.
15. Donnelly, R.F., Morrissey, A., McCarron, P.A., Woolfson, A.D. Microstructured devices for transdermal drug delivery andminimally-invasive patient monitoring. Recent Pat Drug DelivForm 2007 1: 195-200.
16. Donnelly, R.F., Thakur, R.R.S., Woolfson, A.D. Microneedlebaseddrug delivery systems: microfabrication. Drug Deliv Saf 2010 17: 1-24.
17. Thakur RRS, Majithiya R, Demir YK, Shaikh R, Donnelly RF. Microneedle magic. Pharm Manuf Packing Sourcer 2010; (48): 26-29.
18. Kaushik S, Allen HH, Donald DD, Devin VM, Sudhasinee S, Mark GA, et al. Lack of pain associated with microfabricatedmicroneedles. Anesth Analg 2001; 92: 502-4.
19. Verbaan FJ, Bal SM, Van den Berg DJ, Dijksman JA, van Hecke M, Verpoorten H, et al. Improved piercing of microneedle arrays indermatomed human skin by an impact insertion method. J ControlRelease 2008; 128: 80-8.
20. Verbaan FJ, Bal SM, Van den Berg DJ, Groenink WHH, Verpoorten H, Lüttge R, et al. Assembled microneedle arraysenhance the transport of compounds varying over a large range ofmolecular weight across human dermatomed skin. J ControlRelease 2007; 117: 238-45.
21. Lee, J., Hong, S.H. Microneedle roller. US20080161735 (2008).
22. rd August 2010].
23. Nanogen. http://nanogen.co.uk/nanogen-scalproller-hair-growthstimulator.html [Accessed on 23rd August 2010].
24. Cormier, M.J.N., Young, W.A., Johson, J.A., Daddona, P.E., Ameri, M. Transdermal drug delivery devices having coatedmicroprotrusions. WO2004002566 (2004) & US20060200069(2006).
25. Trautman, J.C., Keenan, R.L. Microprotrusion member retainer forimpact applicator. US6855131 (2005).
26. rdAugust 2010].
27. Trautman, J.C., Olson, L. Self-actuating applicator formicroprojection array. US7097631 (2006).
28. Trautman, J.C., Worsham, R.W., Bayramov, D.F., Bowers, D.F., Klemm, S.R., Singh, P. Applicators for microneedles arrays.US2008000824 (2008).
29. rd August 2010].
30. Gary C. The Emergence of Active Transdermal Drug Delivery;Controlled Release Society Annual Meeting. Copenhagen, Denmark 2009; 18-22 July.
31. Clarke, G. M., Delmore, M. D., Domroese, M. K., Ferber, R.H., Jacobs, J.D., Keister, J.C., Frederickson, F.L. Microneedle devicesand microneedle delivery apparatus. US0261631 (2005).
32. Ringsred, T.K., Frederickson, F.L. Microneedle array applicatorand retainer. US20080009825 (2008).
33. Cantor A.S. Non-skin-contacting microneedle array applicator.US20080009811 (2008).
34. Cantor, A.S., Frederickson, F.L., Johnson, P.R., Ringsred, T.K. Low-profile microneedle array applicator. US20080114298 (2008).
35. Simons, J.K., Frederickson, F.L. Device for applying a microneedlearray. US20090198189 (2009).
36. Frederickson, F.L., Johnson, M.D., Wirtanen, D.J. Collapsiblepatch and method of application. US20080195035 (2008).
37. Prausnitz, M.R., Allen, M.G., Henry, S., McAllister, D.V., Ackley, D.E., Jackosn, T. Devices and methods for enhanced microneedlepenetration of biological barriers. US6743211 (2004).
38. rd August 2010].
39. Yuzhakov, V.V. Microneedle array, patch, and applicator for transdermal drug delivery. US20070161964 (2007) andUS7658728 (2010).
40. Tobinaga, Y., Sugiyama, S. Applicator for applying functionalsubstances into human skin. US20050065463 (2005).
41. Withey, E.L. High-speed vaccination device. US0106207 (2007).
42. Henley, J.L. Iontosonic-microneedle applicator apparatus and methods. US0276318 (2007).
43. Yeshurun, Y., Levin, Y., Hefetz, M., Sefi, Y., Lavi, G. Microneedleadaptor for dosed drug delivery devices. US20090247953 (2009).
44. Petits, R.J., Martin, F.E., Chastener, S.A. Microneedle-based pendevice for drug delivery and method for using same. US7556615(2009).
45. BD Available online at: http://www.bd.com/pharmaceuticals/products/microinjection.asp [Accessed online on 23rd August2010].
46. Laurent A, Mistretta F, Bottigioli D, Dahel K, Goujon C, Nicolas JF, et al. Echographic measurement of skin thickness in adults byhigh frequency ultrasound to assess the appropriate microneedlelength for intradermal delivery of vaccines. Vaccine 2007; 25:6423-30.
47. Laurent P, Stephane B, Paul A, Paulina R, John AM, Ronald P. Evaluation of the clinical performance of a new intradermalvaccine administration technique and associated delivery system.Vaccine 2007; 25: 8833-42.
48. Eriksson, E., Baker, C., Allison, W.R., Johnson, T., Dowing, A., Porait, D., Labombard, D., Navickas, J., Guiney, P. Microseedingdevice for gene delivery by microneedle injection. US7422574(2008).
49. Donnelly, R.F., Garland, M.J., Morrow, D.I.J., Migalska, K., Thakur, R.R.S., Majithiya, R., Woolfson, A.D. Optical coherencetomography is a valuable tool in the study of the effects of micro needle geometry on skin penetration characteristics and in skin dissolution. J Control Release 2010; 147(3): 333-41.
50. Gomaa, Y.A., Morrow, D.I.J., Garland, M.J., Donnelly, R.F., El-Khordagui, L.K., Meidan, V.M. Effects of microneedle length,density, insertion time and multiple applications on human skinbarrier function: assessments by transepidermal water loss. ToxicolIn Vitro 2010; 24: 1971-78.
51. Nanogen. http://www.hairfantastic.co.uk/cart.php [Accessed on14th November 2010].